Catalyst Wire Dossier Catalyst Wire Dossier

JIDEYTRO

ZIDESAMTINIB · Nuvalent, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for JIDEYTRO, covering 2026-07-22 to 2026-07-22. Get the full timeline:

Most recent: FDA Approved: JIDEYTRO — Original Application (Nuvalent, Inc.)

See pricing